Das K, Geng X, Brown J, Morales-Oyarvide V, Huynh T, Pergolini I
Gastroenterology. 2019; 157(3):720-730.e2.
PMID: 31175863
PMC: 6707850.
DOI: 10.1053/j.gastro.2019.05.014.
Tokue H, Morita H, Tokue A, Tsushima Y
SAGE Open Med Case Rep. 2017; 5:2050313X17741014.
PMID: 29163954
PMC: 5686876.
DOI: 10.1177/2050313X17741014.
Yoshida K, Nagasaka T, Umeda Y, Tanaka T, Kimura K, Taniguchi F
J Cancer Res Clin Oncol. 2016; 142(7):1557-69.
PMID: 27095449
PMC: 4899496.
DOI: 10.1007/s00432-016-2164-x.
Brugge W
J Gastrointest Oncol. 2015; 6(4):375-88.
PMID: 26261724
PMC: 4502158.
DOI: 10.3978/j.issn.2078-6891.2015.057.
Marwah S, Marwah N, Garg S, Mathur S
Clin J Gastroenterol. 2015; 4(4):262-265.
PMID: 26189531
DOI: 10.1007/s12328-011-0231-z.
Endoscopic ultrasound in the diagnosis of pancreatic intraductal papillary mucinous neoplasms.
Efthymiou A, Podas T, Zacharakis E
World J Gastroenterol. 2014; 20(24):7785-93.
PMID: 24976716
PMC: 4069307.
DOI: 10.3748/wjg.v20.i24.7785.
mAb Das-1 is specific for high-risk and malignant intraductal papillary mucinous neoplasm (IPMN).
Das K, Xiao H, Geng X, Fernandez-Del-Castillo C, Morales-Oyarvide V, Daglilar E
Gut. 2013; 63(10):1626-34.
PMID: 24277729
PMC: 5614500.
DOI: 10.1136/gutjnl-2013-306219.
Laparoscopic pancreatic resections.
Bausch D, Keck T
Langenbecks Arch Surg. 2013; 398(7):939-45.
PMID: 24006117
DOI: 10.1007/s00423-013-1108-z.
Intraductal papillary mucinous neoplasms of the pancreas: is the puzzle solved?.
Balsarkar D, Takahata S, Tanaka M
Indian J Gastroenterol. 2013; 32(4):213-21.
PMID: 23512214
DOI: 10.1007/s12664-013-0327-0.
Intraductal papillary mucinous adenocarcinoma of the pancreas: clinical outcomes, prognostic factors, and the role of adjuvant therapy.
Alexander B, Fernandez-Del Castillo C, Ryan D, Kachnic L, Hezel A, Niemierko A
Gastrointest Cancer Res. 2012; 4(4):116-21.
PMID: 22368734
PMC: 3283102.
Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes.
Mino-Kenudson M, Fernandez-Del Castillo C, Baba Y, Valsangkar N, Liss A, Hsu M
Gut. 2011; 60(12):1712-20.
PMID: 21508421
PMC: 3806085.
DOI: 10.1136/gut.2010.232272.
Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratio.
Partelli S, Fernandez-Del Castillo C, Bassi C, Mantovani W, Thayer S, Crippa S
Ann Surg. 2010; 251(3):477-82.
PMID: 20142730
PMC: 3135381.
DOI: 10.1097/SLA.0b013e3181cf9155.
Multifocal intraductal papillary mucinous neoplasm of the pancreas--a case report.
Chiang K, Hsu J, Chen H, Jwo S, Hwang T, Jan Y
World J Gastroenterol. 2009; 15(5):628-32.
PMID: 19195068
PMC: 2653357.
DOI: 10.3748/wjg.15.628.
Endoscopic ultrasonography for evaluating patients with recurrent pancreatitis.
Petrone M, Arcidiacono P, Testoni P
World J Gastroenterol. 2008; 14(7):1016-22.
PMID: 18286681
PMC: 2689402.
DOI: 10.3748/wjg.14.1016.
Intraductal papillary mucinous neoplasm associated with incomplete pancreas divisum as a cause of acute recurrent pancreatitis.
Sterling M, Giordano S, Sedarat A, Belitsis K
Dig Dis Sci. 2006; 52(1):262-6.
PMID: 17171445
DOI: 10.1007/s10620-006-9543-0.
MUC1 and MUC2 in pancreatic neoplasia.
Levi E, Klimstra D, Andea A, Basturk O, Adsay N
J Clin Pathol. 2004; 57(5):456-62.
PMID: 15113850
PMC: 1770304.
DOI: 10.1136/jcp.2003.013292.
Cystic Lesions of the Pancreas.
Brugge W
Curr Treat Options Gastroenterol. 2002; 5(5):325-330.
PMID: 12207855
DOI: 10.1007/s11938-002-0020-3.
